Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: Exploratory study of parasite load and clinical parameters

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1826-1833

  Jara, Marlene ^a   Adaui, Vanessa ^a,b   Valencia, Braulio M ^a   Martinez, Dalila ^a,c   Alba, Milena ^a   Castrillon, Carlos ^a   Cruz, Maria ^d   Cruz, Israel ^e   Van Der Auwera, Gert ^c   Llanos Cuentas, Alejandro ^a,f   Dujardin, Jean Claude ^c,g   Arevalo, Jorge ^a,b  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Hospital Nacional Adolfo Guevara Velasco EsSalud   (Peru)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^g UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; KINETOPLAST DNA;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; EXPLORATORY RESEARCH; G6PD GENE; GENE; HUMAN; HUMAN TISSUE; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA PERUVIANA; MAJOR CLINICAL STUDY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE LOAD; PARASITE VIRULENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN DEFECT; SKIN LEISHMANIASIS; VALIDATION PROCESS;

ADULT; DNA, KINETOPLAST; DNA, PROTOZOAN; FEMALE; HUMANS; LEISHMANIA; LEISHMANIASIS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PARASITE LOAD; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SKIN;

VIANNIA;

EID: 84878473073     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00208-13     Document Type: Article

References (47)

1. McMahon-Pratt D, Alexander J. 2004. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol. Rev. 201:206-224. (Pubitemid 39318454)
2. Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verastegui C, Lazo M, Loayza-Muro R, De Doncker S, Maurer A, Chappuis F, Dujardin JC, Llanos-Cuentas A. 2007. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J. Infect. Dis. 195:1846-1851. (Pubitemid 46870258)
3. David CV, Craft N. 2009. Cutaneous and mucocutaneous leishmaniasis. Dermatol. Ther. 22:491-502.
4. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. 2007. Cutaneous leishmaniasis. Lancet Infect. Dis. 7:581-596. (Pubitemid 47277438)
5. Santrich C, Segura I, Arias AL, Saravia NG. 1990. Mucosal disease caused by Leishmania braziliensis guyanensis. Am. J. Trop. Med. Hyg. 42:51-55. (Pubitemid 20060511)
6. Osorio LE, Castillo CM, Ochoa MT. 1998. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics. Am. J. Trop. Med. Hyg. 59:49-52. (Pubitemid 28304796)
7. Mary C, Faraut F, Drogoul MP, Xeridat B, Schleinitz N, Cuisenier B, Dumon H. 2006. Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am. J. Trop. Med. Hyg. 75:858-863. (Pubitemid 351627530)
8. van der Meide WF, Peekel I, van Thiel PP, Schallig HD, de Vries HJ, Zeegelaar JE, Faber WR. 2008. Treatment assessment by monitoring parasite load in skin biopsies from patients with cutaneous leishmaniasis, using quantitative nucleic acid sequence-based amplification. Clin. Exp. Dermatol. 33:394-399. (Pubitemid 351832125)
9. Romero I, Téllez J, Suárez Y, Cardona M, Figueroa R, Zelazny A, Saravia NG. 2010. Viability and burden of Leishmania in extralesional sites during human dermal leishmaniasis. PLoS Negl. Trop. Dis. 4:e819. doi:10.1371/journal.pntd.0000819.
10. Maurya R, Mehrotra S, Prajapati VK, Nylén S, Sacks D, Sundar S. 2010. Evaluation of blood agar microtiter plates for culturing Leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis. J. Clin. Microbiol. 48:1932-1934.
11. Titus RG, Marchand M, Boon T, Louis JA. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555. (Pubitemid 16256170)
12. Zhang W-W, Miranda-Verastegui C, Arevalo J, Ndao M, Ward B, Llanos-Cuentas A, Matlashewski G. 2006. Development of a genetic assay to distinguish between Leishmania Viannia species on the basis of isoenzyme differences. Clin. Infect. Dis. 42:801-809. (Pubitemid 43363936)
13. Cummings KL, Tarleton RL. 2003. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129:53-59. (Pubitemid 36703222)
14. Lin M-H, Chen T-C, Kuo T-T, Tseng C-C, Tseng C-P. 2000. Real-time PCR for quantitative detection of Toxoplasma gondii. J. Clin. Microbiol. 38:4121-4125. (Pubitemid 32233214)
15. Kamau E, Tolbert LS, Kortepeter L, Pratt M, Nyakoe N, Muringo L, Ogutu B, Waitumbi JN, Ockenhouse CF. 2011. Development of a highly sensitive genus-specific quantitative reverse transcriptase real-time PCR assay for detection and quantitation of Plasmodium by amplifying RNA and DNA of the 18S rRNA genes. J. Clin. Microbiol. 49:2946-2953.
16. Verma S, Kumar R, Katara GK, Singh LC, Negi NS, Ramesh V, Salotra P. 2010. Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One 5:e10107. doi:10.1371/journal.pone.0010107.
17. Mary C, Faraut F, Lascombe L, Dumon H. 2004. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J. Clin. Microbiol. 42:5249-5255. (Pubitemid 39506237)
18. Sudarshan M, Weirather JL, Wilson ME, Sundar S. 2011. Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis. J. Antimicrob. Chemother. 66:1751-1755.
19. Castilho TM, Camargo LM, McMahon-Pratt D, Shaw JJ, Floeter-Winter LM. 2008. A real-time polymerase chain reaction assay for the identification and quantification of American Leishmania species on the basis of glucose-6-phosphate dehydrogenase. Am. J. Trop. Med. Hyg. 78:122-132. (Pubitemid 351844506)
20. Weirather JL, Jeronimo SM, Gautam S, Sundar S, Kang M, Kurtz MA, Haque R, Schriefer A, Talhari S, Carvalho EM, Donelson JE, Wilson ME. 2011. Serial quantitative PCR assay for detection, species-discrimination and quantification of Leishmania spp. in human samples. J. Clin. Microbiol. 49:3892-3904.
21. Pita-Pereira D, Lins R, Oliveira MP, Lima RB, Pereira BA, Moreira OC, Brazil RP, Britto C. 2012. SYBR green-based real-time PCR targeting kinetoplast DNA can be used to discriminate between the main etiologic agents of Brazilian cutaneous and visceral leishmaniases. Parasit. Vectors 5:15. doi:10.1186/1756-3305-5-15.
22. Tobie EJ, von-Brand T, Mehlman B. 2001. Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense. 1949. J. Parasitol. 87:714-717. (Pubitemid 32783161)
23. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG. 2003. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 49:7-18. (Pubitemid 36078547)
24. Lopez M, Inga R, Cangalaya M, Echevarria J, Llanos-Cuentas A, Orrego C, Arevalo J. 1993. Diagnosis of Leishmania using the polymerase chain reaction: a simplified procedure for field work. Am. J. Trop. Med. Hyg. 49:348-356. (Pubitemid 23289394)
25. Boggild AK, Valencia BM, Espinosa D, Veland N, Ramos AP, Arevalo J, Llanos-Cuentas A, Low DE. 2010. Detection and species identification of Leishmania DNA from filter paper lesion impressions for patients with American cutaneous leishmaniasis. Clin. Infect. Dis. 50:e1-e6. doi:10.1086/648730.
26. Veland N, Boggild AK, Valencia C, Valencia BM, Llanos-Cuentas A, Van der Auwera G, Dujardin JC, Arevalo J. 2012. Leishmania (Viannia) species identification on clinical samples from cutaneous leishmaniasis patients in Peru: assessment of a molecular stepwise approach. J. Clin. Microbiol. 50:495-498.
27. Yuan CC, Miley W, Waters D. 2001. A quantification of human cells using an ERV-3 real time PCR assay. J. Virol. Methods 91:109-117. (Pubitemid 32119328)
28. Adaui V, Verdonck K, Best I, González E, Tipismana M, Arévalo J, Vanham G, Campos M, Zimic M, Gotuzzo E. 2006. SYBR green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. J. Neurovirol. 12:456-465. (Pubitemid 44911566)
29. Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters N, Adlem E, Tivey A, Aslett M, Kerhornou A, Ivens A, Fraser A, Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance Z, Jagels K, Moule S, Ormond D, Rutter S, Squares R, Whitehead S, Rabbinowitsch E, Arrowsmith C, White B, Thurston S, Bringaud F, Baldauf SL, Faulconbridge A, Jeffares D, Depledge DP, Oyola SO, Hilley JD, Brito LO, Tosi LR, Barrell B, Cruz AK, Mottram JC, Smith DF, Berriman M. 2007. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat. Genet. 39:839-847. (Pubitemid 47014491)
30. Shapiro TA, Englund PT. 1995. The structure and replication of kinetoplast DNA. Annu. Rev. Microbiol. 49:117-143.
31. Gutierrez Y, Salinas GH, Palma G, Valderrama LB, Santrich CV, Saravia NG. 1991. Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection. Am. J. Trop. Med. Hyg. 45:281-289.
32. Azogue E. 1983. Diagnóstico histopatológico de la leishmaniasis cutánea y cutáneo-mucosa en Bolivia. Mem. Inst. Oswaldo Cruz 78:13-20.
33. Nylén S, Eidsmo L. 2012. Tissue damage and immunity in cutaneous leishmaniasis. Parasite Immunol. 34:551-561.
34. Carvalho LP, Passos S, Schriefer A, Carvalho EM. 2012. Protective and pathologic immune responses in human tegumentary leishmaniasis. Front. Immunol. 3:301. doi:10.3389/fimmu.2012.00301.
35. Barral A, Almeida RP, de Jesus AR, Medeiros Neto E, Santos IA, Johnson W, Jr. 1987. The relevance of characterizing Leishmania from cutaneous lesions. A simple approach for isolation. Mem. Inst. Oswaldo Cruz 82:579.
36. Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE. 2009. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol. 31:423-431.
37. Maurer-Cecchini A, Decuypere S, Chappuis F, Alexandrenne C, De Doncker S, Boelaert M, Dujardin JC, Loutan L, Dayer JM, Tulliano G, Arevalo J, Llanos-Cuentas A, Chizzolini C. 2009. Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. Infect. Immun. 77:2022-2029.
38. Weigle KA, Labrada LA, Lozano C, Santrich C, Barker DC. 2002. PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). J. Clin. Microbiol. 40:601-606. (Pubitemid 34130887)
39. Kumar R, Bumb RA, Salotra P. 2009. Correlation of parasitic load with interleukin-4 response in patients with cutaneous leishmaniasis due to Leishmania tropica. FEMS Immunol. Med. Microbiol. 57:239-246.
40. Romero GA, Vinitius de Farias Guerra M, Gomes Paes M, de Oliveira Macêdo V. 2001. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: clinical findings and diagnostic approach. Clin. Infect. Dis. 32:1304-1312. (Pubitemid 32405902)
41. Schulz A, Mellenthin K, Schönian G, Fleischer B, Drosten C. 2003. Detection, differentiation, and quantitation of pathogenic Leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J. Clin. Microbiol. 41:1529-1535. (Pubitemid 36428100)
42. Tupperwar N, Vineeth V, Rath S, Vaidya T. 2008. Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen. Diagn. Microbiol. Infect. Dis. 61:23-30. (Pubitemid 351509751)
43. Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, Cotton JA, Hilley JD, De Doncker S, Maes I, Mottram JC, Quail MA, Rijal S, Sanders M, Schönian G, Stark O, Sundar S, Vanaerschot M, Hertz-Fowler C, Dujardin JC, Berriman M. 2011. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res. 21:2143-2156.
44. Sterkers Y, Lachaud L, Crobu L, Bastien P, Pagès M. 2011. FISH analysis reveals aneuploidy and continual generation of chromosomal mosaicism in Leishmania major. Cell Microbiol. 13:274-283.
45. de Oliveira Camera P, Junger J, do Espírito Santo Silva Pires F, Mattos M, Oliveira-Neto MP, Fernandes O, Pirmez C. 2006. Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 100:1112-1117. (Pubitemid 44467740)
46. Vergel C, Palacios R, Cadena H, Posso CJ, Valderrama L, Perez M, Walker J, Travi BL, Saravia NG. 2006. Evidence for Leishmania (Viannia) parasites in the skin and blood of patients before and after treatment. J. Infect. Dis. 194:503-511. (Pubitemid 44162663)
47. Disch J, Oliveira MC, Orsini M, Rabello A. 2004. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis. Acta Trop. 92:279-283. (Pubitemid 39463300)